These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26680771)

  • 1. DNA methylation in an engineered heart tissue model of cardiac hypertrophy: common signatures and effects of DNA methylation inhibitors.
    Stenzig J; Hirt MN; Löser A; Bartholdt LM; Hensel JT; Werner TR; Riemenschneider M; Indenbirken D; Guenther T; Müller C; Hübner N; Stoll M; Eschenhagen T
    Basic Res Cardiol; 2016 Jan; 111(1):9. PubMed ID: 26680771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of DNA methylation attenuates pressure overload-induced cardiac hypertrophy in rats.
    Stenzig J; Schneeberger Y; Löser A; Peters BS; Schaefer A; Zhao RR; Ng SL; Höppner G; Geertz B; Hirt MN; Tan W; Wong E; Reichenspurner H; Foo RS; Eschenhagen T
    J Mol Cell Cardiol; 2018 Jul; 120():53-63. PubMed ID: 29792884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology.
    Hirt MN; Werner T; Indenbirken D; Alawi M; Demin P; Kunze AC; Stenzig J; Starbatty J; Hansen A; Fiedler J; Thum T; Eschenhagen T
    J Mol Cell Cardiol; 2015 Apr; 81():1-9. PubMed ID: 25633833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic signaling compensates for contractile and metabolic consequences of DNA methyltransferase 3A loss in human cardiomyocytes.
    Madsen A; Krause J; Höppner G; Hirt MN; Tan WLW; Lim I; Hansen A; Nikolaev VO; Foo RSY; Eschenhagen T; Stenzig J
    J Mol Cell Cardiol; 2021 May; 154():115-123. PubMed ID: 33582159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased afterload induces pathological cardiac hypertrophy: a new in vitro model.
    Hirt MN; Sörensen NA; Bartholdt LM; Boeddinghaus J; Schaaf S; Eder A; Vollert I; Stöhr A; Schulze T; Witten A; Stoll M; Hansen A; Eschenhagen T
    Basic Res Cardiol; 2012 Nov; 107(6):307. PubMed ID: 23099820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes.
    Kao YH; Chen YC; Cheng CC; Lee TI; Chen YJ; Chen SA
    Crit Care Med; 2010 Jan; 38(1):217-22. PubMed ID: 19730253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice.
    Stöhr A; Friedrich FW; Flenner F; Geertz B; Eder A; Schaaf S; Hirt MN; Uebeler J; Schlossarek S; Carrier L; Hansen A; Eschenhagen T
    J Mol Cell Cardiol; 2013 Oct; 63():189-98. PubMed ID: 23896226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene profiling during regression of pressure overload-induced cardiac hypertrophy.
    Yang DK; Choi BY; Lee YH; Kim YG; Cho MC; Hong SE; Kim DH; Hajjar RJ; Park WJ
    Physiol Genomics; 2007 Jun; 30(1):1-7. PubMed ID: 17327491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel microRNAs negatively regulating cardiac hypertrophy.
    Jeong MH; Lee JS; Kim DH; Park WJ; Yang DK
    Biochem Biophys Res Commun; 2012 Nov; 428(1):191-6. PubMed ID: 23068096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Important Role for DNMT3A-Mediated DNA Methylation in Cardiomyocyte Metabolism and Contractility.
    Madsen A; Höppner G; Krause J; Hirt MN; Laufer SD; Schweizer M; Tan WLW; Mosqueira D; Anene-Nzelu CG; Lim I; Foo RSY; Hansen A; Eschenhagen T; Stenzig J
    Circulation; 2020 Oct; 142(16):1562-1578. PubMed ID: 32885664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cAMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes.
    Fang X; Robinson J; Wang-Hu J; Jiang L; Freeman DA; Rivkees SA; Wendler CC
    Am J Physiol Cell Physiol; 2015 Sep; 309(6):C425-36. PubMed ID: 26224577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone acetylation is essential for ANG-II-induced IGF-IIR gene expression in H9c2 cardiomyoblast cells and pathologically hypertensive rat heart.
    Chu CH; Lo JF; Hu WS; Lu RB; Chang MH; Tsai FJ; Tsai CH; Weng YS; Tzang BS; Huang CY
    J Cell Physiol; 2012 Jan; 227(1):259-68. PubMed ID: 21412773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes.
    Uesugi M; Ojima A; Taniguchi T; Miyamoto N; Sawada K
    J Pharmacol Toxicol Methods; 2014; 69(2):177-88. PubMed ID: 24296355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue.
    Tiburcy M; Didié M; Boy O; Christalla P; Döker S; Naito H; Karikkineth BC; El-Armouche A; Grimm M; Nose M; Eschenhagen T; Zieseniss A; Katschinksi DM; Hamdani N; Linke WA; Yin X; Mayr M; Zimmermann WH
    Circ Res; 2011 Oct; 109(10):1105-14. PubMed ID: 21921264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of miR-140-3p prevents functional deterioration in afterload-enhanced engineered heart tissue.
    Werner TR; Kunze AC; Stenzig J; Eschenhagen T; Hirt MN
    Sci Rep; 2019 Aug; 9(1):11494. PubMed ID: 31391475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
    Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor.
    Diniz GP; Lino CA; Guedes EC; Moreira Ldo N; Barreto-Chaves ML
    Basic Res Cardiol; 2015 Sep; 110(5):49. PubMed ID: 26202011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dystrophin upregulation in pressure-overloaded cardiac hypertrophy in rats.
    Maeda M; Biro S; Kamogawa Y; Hirakawa T; Setoguchi M; Tei C
    Cell Motil Cytoskeleton; 2003 May; 55(1):26-35. PubMed ID: 12673596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to beta-adrenergic receptor stimulation.
    Tomita H; Nazmy M; Kajimoto K; Yehia G; Molina CA; Sadoshima J
    Circ Res; 2003 Jul; 93(1):12-22. PubMed ID: 12791704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-328 as a regulator of cardiac hypertrophy.
    Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
    Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.